These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15782082)

  • 1. Steady-state pharmacokinetics of bupropion SR in juvenile patients.
    Daviss WB; Perel JM; Rudolph GR; Axelson DA; Gilchrist R; Nuss S; Birmaher B; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2005 Apr; 44(4):349-57. PubMed ID: 15782082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
    Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study.
    Daviss WB; Perel JM; Brent DA; Axelson DA; Rudolph GR; Gilchrist R; Nuss S; Birmaher B
    Ther Drug Monit; 2006 Apr; 28(2):190-8. PubMed ID: 16628130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
    Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
    J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
    Zhang F; Li Y; Hu J; Zhong J; Li H
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.
    Daviss WB; Bentivoglio P; Racusin R; Brown KM; Bostic JQ; Wiley L
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):307-14. PubMed ID: 11288772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion sustained release: a therapeutic overview.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
    Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
    J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related reduction in bupropion plasma concentrations by ritonavir.
    Park J; Vousden M; Brittain C; McConn DJ; Iavarone L; Ascher J; Sutherland SM; Muir KT
    J Clin Pharmacol; 2010 Oct; 50(10):1180-7. PubMed ID: 20484617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.
    Laib AK; Brünen S; Pfeifer P; Vincent P; Hiemke C
    Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
    Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
    Drug Metab Dispos; 2014 Nov; 42(11):1971-7. PubMed ID: 25187485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects.
    Oh DA; Crean CS
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):346-53. PubMed ID: 27137143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion.
    Kustra R; Corrigan B; Dunn J; Duncan B; Hsyu PH
    J Clin Pharmacol; 1999 Nov; 39(11):1184-8. PubMed ID: 10579150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers.
    Hesse LM; Greenblatt DJ; von Moltke LL; Court MH
    J Clin Pharmacol; 2006 May; 46(5):567-76. PubMed ID: 16638740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers.
    Masters AR; Gufford BT; Lu JB; Metzger IF; Jones DR; Desta Z
    J Pharmacol Exp Ther; 2016 Aug; 358(2):230-8. PubMed ID: 27255113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population.
    Stang P; Suppapanaya N; Hogue SL; Park D; Rigney U
    Am J Ther; 2007; 14(3):241-6. PubMed ID: 17515697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
    Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
    Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression.
    Sweet RA; Pollock BG; Kirshner M; Wright B; Altieri LP; DeVane CL
    J Clin Pharmacol; 1995 Sep; 35(9):876-84. PubMed ID: 8786247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion plasma levels and CYP2D6 phenotype.
    Pollock BG; Sweet RA; Kirshner M; Reynolds CF
    Ther Drug Monit; 1996 Oct; 18(5):581-5. PubMed ID: 8885123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.